Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation.

Trial Profile

Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2015

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Phenprocoumon
  • Indications Embolism; Stroke; Venous thromboembolism
  • Focus Therapeutic Use
  • Acronyms Dabi-ADP-1
  • Most Recent Events

    • 19 Sep 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 24 Apr 2012 Planned end date changed from 1 Apr 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 14 Mar 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-000503-40).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top